BlockBeats News, January 15th, according to GMGN monitoring, a trader started continuous buying after the market cap of the Meme coin "I'm Coming" exceeded 39 million USD, spending a total of 99,700 USD to build a position. The trader sold in batches to stop loss after the token's market cap fell below 17 million USD, selling back and redeeming 26,200 USD, still holding "I'm Coming" worth 11,000 USD, currently experiencing a loss of 62.25%.
Previously, the trader entered at the high point for the Meme coins "Cultivation," "Financial Freedom," and "meme rush," losing 63,800 USD, 60,500 USD, and 54,500 USD respectively.
BlockBeats Note: Meme coins are highly volatile, relying heavily on market sentiment and concept hype, without actual value or use case. Investors should be aware of the risks.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.



Key Takeaways: Changpeng Zhao’s memoir, “Freedom of Money,” provides a detailed personal account of his ascent, challenges, and…





Key Takeaways Coinbase challenges a banking regulation it labels “political,” highlighting the pressure banks face to cut ties…

Key Takeaways Poland’s President Karol Nawrocki vetoed the proposed Cryptoasset Market Act over concerns about freedom and government…

Key Takeaways FastLane is introducing shMON, a revolutionary liquid staking token in the Monad ecosystem that enhances user…

Key Takeaways: Digital wallets are maturing beyond asset storage, evolving into multifaceted identity hubs and gateways. They empower…

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.



Key Takeaways: Changpeng Zhao’s memoir, “Freedom of Money,” provides a detailed personal account of his ascent, challenges, and…